Interest of Using Balanced Fluid for Infusion at the Early Phase of an Acute Cranial Trauma for Limiting Hyperchloremic Acidosis
IsoTC
Intérêt d'Utiliser Des solutés de Remplissage équilibrés à la Phase précoce d'un Traumatisme crânien Grave Pour Limiter l'Acidose hyperchlorémique
1 other identifier
interventional
42
1 country
1
Brief Summary
isotonic NaCl serum is the first intent solution for infusion during the initial phase of reanimation for an acute cranial traumatism. However, its use can trigger an hyperchloremic metabolic acidosis, what could be deleterious for the future of this patient. Isofundine present all charateristics to be use in this indication: pharmacokinetic and pharmacodynamic similar to the physiologic serum, iso-osmolarity to plasma, no glucose provision and no interaction with hemostasis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Oct 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 18, 2009
CompletedFirst Posted
Study publicly available on registry
February 19, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2010
CompletedJanuary 31, 2013
January 1, 2013
2 years
February 18, 2009
January 30, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of hyperchloremic acidosis during the 2 first days of acute cranial traumatism.
J1 and J2
Secondary Outcomes (2)
Incidence of hypokaliemia and hypocalcemia
J1 and J2
Study of treatment effect on the evolution of intracranil pressure.
J1 and J2
Study Arms (2)
1
ACTIVE COMPARATORHeafusine - Physiologic serum
2
EXPERIMENTALIsofundine - Tetraspan
Interventions
Physiological serum: basic flow 30 ml/kg/j during 48 hoursand boli wished by physicians 20 ml/kg on 20 minutes Heafusine: boli 10 ml/kg on 20 minutes
Isofundine: basic flow 30 ml/kg/j during 48 hoursand boli wished by physicians 20 ml/kg on 20 minutes Tetraspan: boli 10 ml/kg on 20 minutes
Eligibility Criteria
You may qualify if:
- Glasgow \< or equal to 8
- Patient \> 18 years old
You may not qualify if:
- Polytraumatism
- Pregnancy
- Patient under guardianship
- renal insufficiency, hypokaliemia, hypocalcemia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Réanimation CHU de Nantes Boulevard Jean Monnet
Nantes, 44093, France
Related Publications (1)
Roquilly A, Loutrel O, Cinotti R, Rosenczweig E, Flet L, Mahe PJ, Dumont R, Marie Chupin A, Peneau C, Lejus C, Blanloeil Y, Volteau C, Asehnoune K. Balanced versus chloride-rich solutions for fluid resuscitation in brain-injured patients: a randomised double-blind pilot study. Crit Care. 2013 Apr 19;17(2):R77. doi: 10.1186/cc12686.
PMID: 23601796DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 18, 2009
First Posted
February 19, 2009
Study Start
October 1, 2008
Primary Completion
October 1, 2010
Study Completion
October 1, 2010
Last Updated
January 31, 2013
Record last verified: 2013-01